Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Publikationen des W. G. Kerckhoff-Instituts     Display Documents



  history
ID: 199064.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Publikationen des W. G. Kerckhoff-Instituts
Regulation of EMAP II by hypoxia
Authors:Matschurat, S.; Knies, U. E.; Person, V.; Fink, L.; Stoelcker, B.; Ebenebe, C.; Behrensdorf, H. A.; Schaper, J.; Clauss, M.
Date of Publication (YYYY-MM-DD):2003-01
Title of Journal:Am J Pathol
Volume:162
Issue / Number:1
Start Page:93
End Page:103
Review Status:not specified
Audience:Not Specified
Abstract / Description:Endothelial-monocyte-activating polypeptide II (EMAP II) is a proinflammatory cytokine and a chemoattractant for monocytes and granulocytes. We have previously shown that EMAP II mRNA is strongly expressed at sites of apoptosis in the mouse embryo and that the mature protein is cleaved from its cellular precursor (proEMAP II/p43) by caspase activation to become released from cells. Here we demonstrate in vivo that EMAP II mRNA expression is strongly increased in tumor necrosis factor alpha (TNF)-treated murine meth A fibrosarcomas and in B16 melanomas, especially in close proximity to areas of tissue necrosis. Furthermore, by means of confocal microscopy, high level expression of proEMAP II/p43 protein correlated predominantly with hypoxic but also with apoptotic cells. In vitro, EMAP II mRNA levels were not increased by hypoxia. However, high amounts of mature EMAP II protein were detected in the supernatants of hypoxic tumor cells. Unlike in apoptotic cells, neither a broad-range caspase inhibitor nor an inhibitor specific for the internal cleavage site was able to inhibit processing of proEMAP II/p43 to the mature EMAP II protein. In conclusion, these data suggest that hypoxia and apoptosis provide two alternative mechanisms of EMAP II generation by tumor cells.
Free Keywords:Animals
; Apoptosis/drug effects
; *Cell Hypoxia
; Cysteine Proteinase Inhibitors/pharmacology
; Cytokines/genetics/*metabolism
; Fibrosarcoma/*metabolism/pathology
; In Situ Hybridization
; Melanoma, Experimental/*metabolism/pathology
; Mice
; Neoplasm Proteins/genetics/*metabolism
; Protein Processing, Post-Translational/drug effects
; RNA, Messenger/metabolism
; RNA-Binding Proteins/genetics/*metabolism
; Reverse Transcriptase Polymerase Chain Reaction
; Support, Non-U.S. Gov't
; Tumor Cells, Cultured/drug effects
External Publication Status:published
Document Type:Article
Communicated by:N. N.
Affiliations:MPI für physiologische und klinische Forschung
Identifiers:URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=... [ID No:1]
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.